Literature DB >> 16026858

Increase in inflammatory cytokines in median nerves in a rat model of repetitive motion injury.

Talal Al-Shatti1, Ann E Barr, Fayez F Safadi, Mamta Amin, Mary F Barbe.   

Abstract

We examined cytokines in rat median nerves following performance of a high repetition reaching and grasping task at a rate of 8 reaches/min for up to 8 weeks. IL-1alpha, IL-1beta, TNF-alpha, IL-6 and IL-10 were analyzed by immunohistochemistry. Double-labeling immunohistochemistry for ED1, a marker of phagocytic macrophages, was also performed. We found increased immunoexpression of IL-6 by week 3, increases in all 5 cytokines by week 5. This response was transient as all cytokines returned to control levels by 8 weeks of performance of a high repetition negligible force task. Cytokine sources included Schwann cells, fibroblasts and phagocytic macrophages (ED1-immunopositive). These findings suggest that cytokines are involved in the pathophysiology of repetitive motion injuries in peripheral nerves.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026858      PMCID: PMC1552098          DOI: 10.1016/j.jneuroim.2005.06.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  36 in total

1.  Detection of cytokines in human sural nerve biopsies: an immunohistochemical and molecular study.

Authors:  M Deprez; U Lübke; M Verlaet; S Debrus; P Delvenne; J J Martin
Journal:  Acta Neuropathol       Date:  2001-04       Impact factor: 17.088

2.  Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain.

Authors:  K Okamoto; D P Martin; J D Schmelzer; Y Mitsui; P A Low
Journal:  Exp Neurol       Date:  2001-06       Impact factor: 5.330

3.  Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury.

Authors:  V I Shubayev; R R Myers
Journal:  Brain Res       Date:  2000-02-07       Impact factor: 3.252

4.  Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury.

Authors:  A George; C Schmidt; A Weishaupt; K V Toyka; C Sommer
Journal:  Exp Neurol       Date:  1999-11       Impact factor: 5.330

Review 5.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

6.  Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA.

Authors:  H S Taskinen; T Olsson; A Bucht; M Khademi; L Svelander; M Röyttä
Journal:  J Neuroimmunol       Date:  2000-01-03       Impact factor: 3.478

Review 7.  Cytokines and neurotrophins interact in normal and diseased states.

Authors:  U Otten; P März; K Heese; C Hock; D Kunz; S Rose-John
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

8.  Interleukin-6 (IL-6) and its soluble receptor support survival of sensory neurons.

Authors:  M Thier; P März; U Otten; J Weis; S Rose-John
Journal:  J Neurosci Res       Date:  1999-02-15       Impact factor: 4.164

9.  Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain.

Authors:  J L Arruda; S Sweitzer; M D Rutkowski; J A DeLeo
Journal:  Brain Res       Date:  2000-10-06       Impact factor: 3.252

10.  The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta.

Authors:  Shlomit Shamash; Fanny Reichert; Shlomo Rotshenker
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

View more
  39 in total

1.  Role of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and grasping.

Authors:  Shobha Rani; Mary F Barbe; Ann E Barr; Judith Litivn
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

2.  Eccentric exercise induces chronic alterations in musculoskeletal nociception in the rat.

Authors:  Pedro Alvarez; Jon D Levine; Paul G Green
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

Review 3.  Inflammation and the pathophysiology of work-related musculoskeletal disorders.

Authors:  Mary F Barbe; Ann E Barr
Journal:  Brain Behav Immun       Date:  2006-05-02       Impact factor: 7.217

Review 4.  [Cytokine regulation and pain. Results of experimental and clinical research].

Authors:  N Uçeyler; C Sommer
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

5.  Long lasting recruitment of immune cells and altered epi-perineurial thickness in focal nerve inflammation induced by complete Freund's adjuvant.

Authors:  Geoffrey M Bove; Wendy Weissner; Mary F Barbe
Journal:  J Neuroimmunol       Date:  2009-06-28       Impact factor: 3.478

6.  Evidence for cFMS signaling in HIV production by brain macrophages and microglia.

Authors:  Lindsey Gerngross; Tracy Fischer
Journal:  J Neurovirol       Date:  2014-07-25       Impact factor: 2.643

7.  Mechanisms mediating vibration-induced chronic musculoskeletal pain analyzed in the rat.

Authors:  Olayinka A Dina; Elizabeth K Joseph; Jon D Levine; Paul G Green
Journal:  J Pain       Date:  2009-12-03       Impact factor: 5.820

8.  Role of interleukin-6 in chronic muscle hyperalgesic priming.

Authors:  O A Dina; P G Green; J D Levine
Journal:  Neuroscience       Date:  2008-01-12       Impact factor: 3.590

9.  Induction of periostin-like factor and periostin in forearm muscle, tendon, and nerve in an animal model of work-related musculoskeletal disorder.

Authors:  Shobha Rani; Mary F Barbe; Ann E Barr; Judith Litvin
Journal:  J Histochem Cytochem       Date:  2009-07-20       Impact factor: 2.479

10.  Combination of G-CSF administration and human amniotic fluid mesenchymal stem cell transplantation promotes peripheral nerve regeneration.

Authors:  Hung-Chuan Pan; Chung-Jung Chen; Fu-Chou Cheng; Shu-Pen Ho; Mu-Jung Liu; Shiaw-Min Hwang; Ming-Hong Chang; Yeou-Chih Wang
Journal:  Neurochem Res       Date:  2008-08-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.